surmount 5 tirzepatide SURMOUNT-5 Trial: vs Semaglutide in Obesity Management SURMOUNT‐1 study design. This is

Within hours, sometimes minutes, a clinician reviews the responses and issues a prescription, which is then filled by a partner compounding pharmacy

Your creative team for digital magic show dedicated to corporate event

After 12 months: Triglycerides fell from 335 to 85 mg/dL HbA1c improved from 7.0% to 5.5% Insulin was discontinued Inflammatory markers normalized No further pancreatitis occurred This single case suggests that tirzepatide may be considered on an individualized basis when metabolic dysfunction is the dominant driver of pancreatitis, even in patients with a #normal #BMI

Suhail M, Suhail MZ, Khan H